Literature DB >> 30334520

Case Report: Subcutaneous Ivermectin Pharmacokinetics in Disseminated Strongyloides Infection: Plasma and Postmortem Analysis.

Pamela Konecny1,2, Christopher J Weatherall1,2, Suman Adhikari1,2, Johan Duflou3,4, Veli Marjoniemi1,2, Carel J Pretorius5,6, Brett McWhinney6.   

Abstract

Parenteral ivermectin treatment of disseminated strongyloidiasis and hyperinfection is increasing, although not licensed in humans and with limited pharmacokinetic data available. Plasma and postmortem tissue analysis in an human immunodeficiency virus (HIV)/hepatitis C virus-positive man with disseminated strongyloidiasis suggests loading subcutaneous ivermectin doses are required, from which the central nervous system is protected.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30334520      PMCID： PMC6283511          DOI： 10.4269/ajtmh.18-0387

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  14 in total

Review 1.  Pharmacokinetics and metabolism of avermectins in livestock.

Authors:  J W Steel
Journal:  Vet Parasitol       Date:  1993-06       Impact factor: 2.738

Review 2.  Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis.

Authors:  Rojelio Mejia; Thomas B Nutman
Journal:  Curr Opin Infect Dis       Date:  2012-08       Impact factor: 4.915

3.  Strongyloides colitis is a lethal mimic of ulcerative colitis: the key morphologic differential diagnosis.

Authors:  Zhenhong Qu; Uma R Kundu; Rania A Abadeer; Audrey Wanger
Journal:  Hum Pathol       Date:  2009-01-13       Impact factor: 3.466

4.  Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.

Authors:  L Einsiedel; L Fernandes
Journal:  Intern Med J       Date:  2008-09       Impact factor: 2.048

Review 5.  Sexual transmission of intestinal parasites in men who have sex with men.

Authors:  Alireza Abdolrasouli; Alexander McMillan; John P Ackers
Journal:  Sex Health       Date:  2009-09       Impact factor: 2.706

6.  Ivermectin: does P-glycoprotein play a role in neurotoxicity?

Authors:  Geoffrey Edwards
Journal:  Filaria J       Date:  2003-10-24

Review 7.  Strongyloidiasis--an insight into its global prevalence and management.

Authors:  Santhosh Puthiyakunnon; Swapna Boddu; Yiji Li; Xiaohong Zhou; Chunmei Wang; Juan Li; Xiaoguang Chen
Journal:  PLoS Negl Trop Dis       Date:  2014-08-14

8.  StrongNet: An International Network to Improve Diagnostics and Access to Treatment for Strongyloidiasis Control.

Authors:  Marco Albonico; Sören L Becker; Peter Odermatt; Andrea Angheben; Mariella Anselmi; Arancha Amor; Beatrice Barda; Dora Buonfrate; Philip Cooper; Laurent Gétaz; Jennifer Keiser; Virak Khieu; Antonio Montresor; José Muñoz; Ana Requena-Méndez; Lorenzo Savioli; Richard Speare; Peter Steinmann; Lisette van Lieshout; Jürg Utzinger; Zeno Bisoffi
Journal:  PLoS Negl Trop Dis       Date:  2016-09-08

Review 9.  Strongyloides stercoralis: a plea for action.

Authors:  Zeno Bisoffi; Dora Buonfrate; Antonio Montresor; Ana Requena-Méndez; Jose Muñoz; Alejandro J Krolewiecki; Eduardo Gotuzzo; Maria Alejandra Mena; Peter L Chiodini; Mariella Anselmi; Juan Moreira; Marco Albonico
Journal:  PLoS Negl Trop Dis       Date:  2013-05-09

Review 10.  Severe strongyloidiasis: a systematic review of case reports.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Jose Muñoz; Federico Gobbi; Jef Van Den Ende; Zeno Bisoffi
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090
View more
  1 in total

1.  Comparison of Loop-Mediated Isothermal Amplification and Real-Time PCR Assays for Detection of Strongyloides Larvae in Different Specimen Matrices.

Authors:  Matthew R Watts; Rady Kim; Vishal Ahuja; Gemma J Robertson; Yasmin Sultana; Michael C Wehrhahn; Richard S Bradbury; Gwendolyn L Gilbert; Rogan Lee
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.